Project Grant R03AG104158
- The National Institute on Aging awarded the University of California, Los Angeles $623,176 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct research on modifiable risk factors for Alzheimer's disease and related dementias among individuals aged 90 and older. The research triangulates evidence across four data sources—the LifeAfter90 Study (1,397 participants, all aged 90), the 90+ Study (1,630 participants, all aged 90), the Health and Retirement Study (3,359...
- The National Institute on Aging awarded the University of Memphis $365,000 on July 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a ten-year longitudinal study examining how cumulative information and communication technology use affects dementia risk among rural community-dwelling older adults. The study tracks information and communication technology use—including smartphones, computers, and internet access—and dementia incidence from 2015 through 2024 using data from the...
- The National Institute on Aging awarded Drexel University $1,306,728 under the Aging Research program (CFDA 93.866) on August 1, 2026, to conduct a longitudinal, multi-site study examining how individual lifestyle, social circumstances, and neighborhood-level factors influence physical functioning trajectories in older adults across population subgroups and U.S. regions. The research leverages over 30 years of longitudinal data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort and...
- The National Institute on Aging awarded the Regents of the University of Michigan $654,999 on September 1, 2026, under the Aging Research program (CFDA 93.866) to assess cognitive functioning in the National Monitoring the Future (MTF) Panel Study. The award funds the addition of web-based cognitive measures to the MTF Panel, a nationally representative longitudinal study of high school seniors followed since 1975. The cognitive measures—assessing memory, numeracy, executive functioning, word...
- The National Institute on Aging awarded Texas A&M University $640,059 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate cerebellar changes in aging and cognitive decline through longitudinal neuroimaging and functional analysis. The project examines how cerebellar structure, white matter circuits, and task-based functional activation change over time in older adults, with particular focus on individuals experiencing subjective cognitive decline—self-reported...
- The National Institute on Aging awarded Drexel University $420,554 under Aging Research (CFDA 93.866) on September 1, 2026, to establish an integrated system for studying senescence and aging in the central nervous system. The award funds two research aims: characterization of the molecular and functional consequences of senescence in astrocyte and neuronal cultures, and evaluation of senescence impact in a multicellular context using hiPSC-derived vascularized cortical organoids. Single-cell...
- The National Institute on Aging awarded $1.669 million to American Institutes For Research In The Behavioral Sciences on September 15, 2025, under the Aging Research program (CFDA 93.866) to develop a comprehensive residential address history for Project Talent participants and geocode addresses to support research on neighborhood characteristics and cognitive health outcomes related to Alzheimer's disease and related dementias. The project will identify Project Talent participants in the...
- The National Institute on Aging awarded New York University $6.203 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to examine peripheral immune markers and vascular dysfunction as contributors to cognitive decline and Alzheimer's disease. The research integrates circulating biomarkers—platelet aggregation, neutrophil activity, and proteomic data—with advanced imaging to assess associations between vascular and immune dysfunction and cerebrovascular burden, amyloid...
- The National Institute on Aging awarded the National Bureau of Economic Research Inc. $427,646 on September 1, 2026, under the Aging Research program (CFDA 93.866) to trace mid-life mortality of birth cohorts born approximately 1940–1960 in the United States by place, time, and family factors. The research combines large-scale administrative datasets—the Numident, Bureau of the Census Numident Mortality Detail file, and Mortality Linkage Project data, containing more than 3.5 million death...
- The National Institute on Aging awarded The Johns Hopkins University $680,637 on September 15, 2026, under the Aging Research program (CFDA 93.866) to conduct a pragmatic clinical trial improving cognitive impairment screening in older adults with diabetes. The funded work develops and validates novel tools using natural language processing and large language models to identify cognitive impairment and Alzheimer's disease and related dementias screening events in electronic health records. The...
The National Institute on Aging awarded the University of Memphis $146,000 on September 4, 2026, under the Aging Research program (CFDA 93.866) to investigate longitudinal patterns of multiple behavioral risk factors and their joint effects on cognitive aging. The recipient will analyze 24 years of data from the Health and Retirement Study, a nationally representative longitudinal survey of U.S. adults age 51 and older, linked with neighborhood contextual data, to examine how physical activity, smoking, alcohol use, body mass index, and social isolation coevolve and influence cognitive aging. The study addresses gaps in current evidence by applying a life-course perspective to multiple behaviors simultaneously rather than examining single timepoint measures in isolation. Aim 1 models longitudinal trajectories of individual behaviors and their demographic and neighborhood determinants. Aim 2 identifies joint multibehavioral trajectories to capture both protective and high-risk clusters. Aim 3 evaluates cumulative and bidirectional associations between behavioral trajectories and cognitive decline, mild cognitive impairment, and dementia incidence across the 1998–2022 period. The project responds to dementia's growing public health burden, with roughly one-third of cases attributable to modifiable lifestyle behaviors. Performance occurs in Memphis, Tennessee, with a period of performance through August 31, 2028. This is a Project Grant, an exploratory or developmental award mechanism under NIA's aging research portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $146.0k | 9/3/26 |